JCI Insight (Sep 2023)

Regulation of human and mouse bystander T cell activation responses by PD-1

  • Catherine T. Le,
  • Logan V. Vick,
  • Craig Collins,
  • Cordelia Dunai,
  • Michael K. Sheng,
  • Lam T. Khuat,
  • Isabel Barao,
  • Sean J. Judge,
  • Ethan G. Aguilar,
  • Brendan Curti,
  • Maneesh Dave,
  • Dan L. Longo,
  • Bruce R. Blazar,
  • Robert J. Canter,
  • Arta M. Monjazeb,
  • William J. Murphy

Journal volume & issue
Vol. 8, no. 18

Abstract

Read online

Bystander activation of memory T cells occurs via cytokine signaling alone in the absence of T cell receptor (TCR) signaling and provides a means of amplifying T cell effector responses in an antigen-nonspecific manner. While the role of Programmed Cell Death Protein 1 (PD-1) on antigen-specific T cell responses is extensively characterized, its role in bystander T cell responses is less clear. We examined the role of the PD-1 pathway during human and mouse non–antigen-specific memory T cell bystander activation and observed that PD-1+ T cells demonstrated less activation and proliferation than activated PD-1– populations in vitro. Higher activation and proliferative responses were also observed in the PD-1– memory population in both mice and patients with cancer receiving high-dose IL-2, mirroring the in vitro phenotypes. This inhibitory effect of PD-1 could be reversed by PD-1 blockade in vivo or observed using memory T cells from PD-1–/– mice. Interestingly, increased activation through abrogation of PD-1 signaling in bystander-activated T cells also resulted in increased apoptosis due to activation-induced cell death (AICD) and eventual T cell loss in vivo. These results demonstrate that the PD-1/PD-Ligand 1 (PD-L1) pathway inhibited bystander-activated memory T cell responses but also protected cells from AICD.

Keywords